Rockwell Medical (FRA:RWMA) Cyclically Adjusted Book per Share: €37.78 (As of Mar. 2026)


FRA:RWMA Rockwell Medical Inc FRA:RWMA
30 GF Score
Price €5.25
GF Value €0.90
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Rockwell Medical Cyclically Adjusted Book per Share?

Rockwell Medical FRA:RWMA 30 Cyclically Adjusted Book per Share is €37.78 as of Mar. 2026. GuruFocus rates FRA:RWMA with a GF Score™ of 30/100 and a GF Value™ of €0.90 (Significantly Overvalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Rockwell Medical's adjusted book value per share for the three months ended in Mar. 2026 was €7.858. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €37.78 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Rockwell Medical's average Cyclically Adjusted Book Growth Rate was -25.80% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -8.70% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -6.00% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was -7.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Rockwell Medical was 14.10% per year. The lowest was -13.50% per year. And the median was -0.45% per year.

As of today (2026-07-03), Rockwell Medical's current stock price is €5.25. Rockwell Medical's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was €37.78. Rockwell Medical's Cyclically Adjusted PB Ratio of today is 0.14.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Rockwell Medical was 8.72. The lowest was 0.12. And the median was 2.03.


Rockwell Medical  (FRA:RWMA) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Rockwell Medical's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=5.25/37.78
=0.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Rockwell Medical was 8.72. The lowest was 0.12. And the median was 2.03.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Rockwell Medical Cyclically Adjusted Book per Share Related Terms


Rockwell Medical Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Rockwell Medical's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rockwell Medical Cyclically Adjusted Book per Share Chart

Rockwell Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 462.44 59.47 623.18 655.12 395.08

Rockwell Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 566.14 460.23 476.31 395.08 37.78

FRA:RWMA vs CPHI, TXMD, MRMD: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Rockwell Medical's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rockwell Medical Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Rockwell Medical's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Rockwell Medical's Cyclically Adjusted PB Ratio falls into.


FRA:RWMA
30GF Score
Rockwell Medical Inc FRA:RWMA
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rockwell Medical Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Rockwell Medical's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=7.858/330.2130*330.2130
=7.858

Current CPI (Mar. 2026) = 330.2130.

Rockwell Medical Quarterly Data

Book Value per Share CPI Adj_Book
201606 109.596 241.018 150.155
201609 106.152 241.428 145.189
201612 107.269 241.432 146.715
201703 100.034 243.801 135.490
201706 83.028 244.955 111.926
201709 72.660 246.819 97.210
201712 59.047 246.524 79.092
201803 47.123 249.554 62.354
201806 30.694 251.989 40.222
201809 23.053 252.439 30.155
201812 46.286 251.233 60.837
201903 34.378 254.202 44.658
201906 45.467 256.143 58.615
201909 37.043 256.759 47.640
201912 30.788 256.974 39.563
202003 31.377 258.115 40.141
202006 22.564 257.797 28.902
202009 41.976 260.280 53.254
202012 33.006 260.474 41.843
202103 25.840 264.877 32.214
202106 17.712 271.696 21.527
202109 11.042 274.310 13.292
202112 2.626 278.802 3.110
202203 -5.111 287.504 -5.870
202206 20.252 296.311 22.569
202209 14.616 296.808 16.261
202212 10.951 296.797 12.184
202303 9.334 301.836 10.212
202306 5.235 305.109 5.666
202309 7.077 307.789 7.593
202312 6.702 306.746 7.215
202403 6.425 312.332 6.793
202406 7.035 314.175 7.394
202409 8.122 315.301 8.506
202412 9.137 315.605 9.560
202503 8.511 319.799 8.788
202506 7.658 322.561 7.840
202509 8.003 324.800 8.136
202512 8.014 324.054 8.166
202603 7.858 330.213 7.858

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €37.78 mean?
Rockwell Medical (FRA:RWMA) has a Cyclically Adjusted Book per Share of €37.78 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Rockwell Medical and its competitors.
Is Rockwell Medical's Cyclically Adjusted Book per Share too high?
Rockwell Medical's current Cyclically Adjusted Book per Share is €37.78. Overall, Rockwell Medical has a GF Score™ of 30/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Rockwell Medical's Cyclically Adjusted Book per Share compare to CPHI and TXMD?
Rockwell Medical's Cyclically Adjusted Book per Share of €37.78 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Rockwell Medical and its competitors. Rockwell Medical's current Cyclically Adjusted Book per Share is €37.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rockwell Medical stock overvalued right now?
Based on GuruFocus' analysis, Rockwell Medical (FRA:RWMA) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.90, compared to a current price of €5.25 — trading 483.3% above its estimated fair value. The current Cyclically Adjusted Book per Share is €37.78. Rockwell Medical's overall GF Score™ is 30/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Rockwell Medical (FRA:RWMA), the current Cyclically Adjusted Book per Share is €37.78 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Rockwell Medical (FRA:RWMA) Overvalued in 2026?

Based on GuruFocus' analysis, Rockwell Medical stock appears to be overvalued. The current stock price of €5.25 is trading 483.3% above its estimated GF Value™ of €0.90. GuruFocus considers Rockwell Medical to be Significantly Overvalued.

Key valuation signals for FRA:RWMA:

  • Cyclically Adjusted Book per Share: €37.78
  • GF Value™: €0.90 vs. price of €5.25 (483.3% above fair value)
  • GF Score™: 30/100 with 3 warning signs

No single metric tells the full story. See the FRA:RWMA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Rockwell Medical Business Description

Other Exchanges RMTI:USA
Address 30142 South Wixom Road, Wixom, MI, USA, 48393
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, acid, and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate, among others. The company delivers the majority of its hemodialysis concentrates products and mixers to dialysis clinics throughout the United States and internationally, utilizing its own delivery trucks and third-party carriers.
30GF Score

Get the complete analysis for FRA:RWMA

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.25
Price
€0.90
GF Value